(2R,3R,3aS,6S,6aR)-6-((2-amino-3-bromoquinolin-7-yl)methyl)-2-(4-cyclopropyl-7H-pyrrolo[2,3-d]pyrimidin-7-yl)hexahydro-2H-cyclopenta[b]furan-3,3a-diol

ID: ALA4849067

PubChem CID: 156503379

Max Phase: Preclinical

Molecular Formula: C26H26BrN5O3

Molecular Weight: 536.43

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Nc1nc2cc(C[C@@H]3CC[C@@]4(O)[C@@H]3O[C@@H](n3ccc5c(C6CC6)ncnc53)[C@@H]4O)ccc2cc1Br

Standard InChI:  InChI=1S/C26H26BrN5O3/c27-18-11-15-2-1-13(10-19(15)31-23(18)28)9-16-5-7-26(34)21(33)25(35-22(16)26)32-8-6-17-20(14-3-4-14)29-12-30-24(17)32/h1-2,6,8,10-12,14,16,21-22,25,33-34H,3-5,7,9H2,(H2,28,31)/t16-,21-,22+,25+,26-/m0/s1

Standard InChI Key:  URRMKEZGOVGAJV-CSFAFAEBSA-N

Molfile:  

 
     RDKit          2D

 36 42  0  0  0  0  0  0  0  0999 V2000
   40.1475  -25.0838    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   40.9573  -24.0369    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.1744  -24.2682    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.4184  -24.7147    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.9176  -25.3556    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.2224  -26.1077    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   42.0278  -26.2201    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.5274  -25.5743    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   42.2199  -24.8247    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.4727  -25.5447    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.7084  -25.2682    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   39.4541  -26.3600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.6700  -26.5899    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.2146  -25.9156    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.4326  -26.1403    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.4046  -26.9535    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.1693  -27.2313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.1026  -26.8572    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   39.0725  -27.2934    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   36.7884  -25.6375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.0309  -25.9440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.3878  -25.4384    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.6309  -25.7443    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.9205  -26.7491    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.1661  -27.0577    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.5204  -26.5527    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.7623  -26.8595    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.6486  -27.6711    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.2992  -28.1750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.0548  -27.8654    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.8917  -27.9791    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
   34.1892  -28.9848    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   42.7202  -24.1786    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.4726  -23.8693    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.8265  -23.3690    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.9994  -25.1224    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
  1  5  1  0
  4  2  1  0
  2  3  2  0
  3  1  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
 10  1  1  1
 10 11  1  0
 11 14  1  0
 13 12  1  0
 12 10  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 13  1  0
 12 18  1  6
 13 19  1  6
 15 20  1  1
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 26  2  0
 25 24  2  0
 24 21  1  0
 25 26  1  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 25  1  0
 28 31  1  0
 29 32  1  0
  9 33  1  0
 34 33  1  0
 35 34  1  0
 33 35  1  0
 14 36  1  6
M  END

Alternative Forms

  1. Parent:

    ALA4849067

    ---

Associated Targets(Human)

PRMT5 Tchem Protein arginine N-methyltransferase 5 (1273 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Z-138 (387 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 536.43Molecular Weight (Monoisotopic): 535.1219AlogP: 3.84#Rotatable Bonds: 4
Polar Surface Area: 119.31Molecular Species: NEUTRALHBA: 8HBD: 3
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.28CX Basic pKa: 5.27CX LogP: 3.97CX LogD: 3.96
Aromatic Rings: 4Heavy Atoms: 35QED Weighted: 0.36Np Likeness Score: 0.52

References

1. Quiroz RV, Reutershan MH, Schneider SE, Sloman D, Lacey BM, Swalm BM, Yeung CS, Gibeau C, Spellman DS, Rankic DA, Chen D, Witter D, Linn D, Munsell E, Feng G, Xu H, Hughes JME, Lim J, Saurí J, Geddes K, Wan M, Mansueto MS, Follmer NE, Fier PS, Siliphaivanh P, Daublain P, Palte RL, Hayes RP, Lee S, Kawamura S, Silverman S, Sanyal S, Henderson TJ, Ye Y, Gao Y, Nicholson B, Machacek MR..  (2021)  The Discovery of Two Novel Classes of 5,5-Bicyclic Nucleoside-Derived PRMT5 Inhibitors for the Treatment of Cancer.,  64  (7.0): [PMID:33755451] [10.1021/acs.jmedchem.0c02083]

Source